Loading clinical trials...

Comparison Study of Blood Glucose Monitoring Systems in People With Diabetes | Clinical Trials | Clareo Health

COMPLETED

Comparison Study of Blood Glucose Monitoring Systems in People With Diabetes

Multicentre Performance Comparison Study of Blood Glucose Monitoring Systems in People With Diabetes Randomised to Multiple Devices

NCT01234727•Abbott Diabetes Care

View on ClinicalTrials.gov

Summary

A Multicentre study comparing 5 different Self-Monitoring Of Blood Glucose (SMBG) system commercially available in Germany \& Holland.

Eligibility

Age

18 - 75 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Subjects diagnosed with type 1 or type 2 diabetes mellitus
•Age between 18 and 75 years.
•Patients with stable blood glucose in judgment of the investigator.
•Subjects receive intensive insulin therapy (Multiple Daily Injection defined as at least two insulin injections per day)
•Patients perform blood glucose self measurements on a routine basis
•Patients must have experience in self measurement blood glucose for at least 6 months.

Exclusion Criteria

•Patients with unstable blood glucose in judgment of the investigator.
•Patient has been diagnosed with progressive / serious diseases that in judgment of the investigator preclude successful completion of the observational period.
•Lack of compliance or other justifications that, in the discretion of the investigator, precludes satisfactory participation in the study.
•Subject without legal capacity.
•Blood donation within the last 30 days.
•Known pregnancy.
•Subject has already participated in the study.

Locations (3)

Zentrum für Diabetes und Gefäßerkrankungen

Münster, Germany

Diabetes Zentrum Neuwied

Neuwied, Germany

Radboud University Nijmegen Centre

Nijmegen, Netherlands

Key Dates

Start Date

December 1, 2010

Primary Completion Date

March 1, 2011

Completion Date

March 1, 2011

Last Updated

March 6, 2026

Enrollment

501

ACTUAL participants

Conditions

Diabetes Mellitus

Genetic Studies of Insulin and Diabetes

NCT00001987

Diabetes MellitusSevere Insulin Resistance

View study

RECRUITINGNA

Feasibility of a Tailored Online Self-compassion Intervention

NCT07051005

Type 1 Diabetes MellitusType 2 Diabetes Mellitus (T2DM)

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 6, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Comparison Study of Blood Glucose Monitoring Systems in People With Diabetes

Inclusion Criteria

Exclusion Criteria

Genetic Studies of Insulin and Diabetes

Feasibility of a Tailored Online Self-compassion Intervention

Mesenchymal Stem Cell and Exosome Therapy for Diabetic Erectile Dysfunction

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

Fasted Exercise Training in Type 1 Diabetes (FED-T1D)

Achieving Routine Intervention and Screening for Emotional Health